MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19

Area of Science:

• Infectious Diseases
• Genetics
• Critical Care Medicine

Background:

• COVID-19 presents diverse clinical phenotypes, from asymptomatic to critical illness.
• Severe outcomes include severe acute respiratory distress syndrome (SARS), multi-organ failure, and death.
• Identifying risk factors for severe COVID-19 is crucial for patient management.

Purpose of the Study:

• To investigate predisposing factors, including MBL2 genotyping, influencing COVID-19 clinical phenotypes.
• To identify predictors of severe disease, pneumonia, and hospitalization in COVID-19 patients.

Main Methods:

• Retrospective analysis of clinical data from 264 COVID-19 patients.
• Evaluation of demographic data, comorbidities, and MBL2 genotyping (rs1800450).
• Statistical analysis to correlate risk factors with disease severity, pneumonia, and hospitalization.

Main Results:

• Older age, obesity, chronic inflammatory disorders, and diabetes mellitus were significant risk factors for hospitalization, pneumonia, and SARS.
• The MBL deficiency-associated B allele (rs1800450) showed a nearly 2-fold increased risk for pneumonia and hospitalization.
• MBL2 genotyping may serve as a molecular predictor for severe COVID-19.

Conclusions:

• Age and specific comorbidities are key determinants of severe COVID-19.
• MBL2 genotype is a potential biomarker for predicting severe respiratory complications in SARS-CoV-2 infection.
• Understanding these factors can improve risk stratification and clinical decision-making for COVID-19 patients.